This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) shed 2.69% to $127.57 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.13% to 7,609.78 and the Dow Jones Industrial Average rising 0.45% to 51,307.79.
This was the stock's third consecutive day of losses.
Gilead Sciences Inc. closed 18.90% short of its 52-week high of $157.29, which the company reached on February 11th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) fell 0.28% to $222.89, Pfizer Inc. (PFE) fell 0.31% to $25.55, and Abbott Laboratories (ABT) fell 0.92% to $86.97.
Trading volume (8.0 M) eclipsed its 50-day average volume of 6.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-02-26 1635ET

GILD

Gilead Sciences (GILD) shares fell 2.69% to $127.57 on Tuesday, underperforming the broader market and key competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. This marks the third consecutive day of losses for Gilead, which remains 18.90% below its 52-week high. Trading volume reached 8.0 million, exceeding the 50-day average.

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors